BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7050637)

  • 1. Pigments and antibiogram of transconjugants from nonpigmented mutants of Serratia marcescens.
    Qian HL; Feng JS; Tsang JC
    Microbios; 1982; 33(132):101-10. PubMed ID: 7050637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid.
    Zhao WH; Hu ZQ; Chen G; Matsushita K; Fukuchi K; Shimamura T
    Microbiol Res; 2007; 162(1):46-52. PubMed ID: 16875810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a red-pigmented bacterium producing a potent anti-tumor N-alkylated prodigiosin as Serratia marcescens.
    Deorukhkar AA; Chander R; Ghosh SB; Sainis KB
    Res Microbiol; 2007 Jun; 158(5):399-404. PubMed ID: 17467243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth depression of Serratia marcescens by plasmids that belong to incompatibility group P.
    Platt DJ; Chesham JS
    Microbios; 1990; 63(256-257):151-7. PubMed ID: 2172750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of prodigiosin by white strains of Serratia marcescens isolated from patients.
    Ding MJ; Williams RP
    J Clin Microbiol; 1983 Mar; 17(3):476-80. PubMed ID: 6341402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigmentation and acriflavine resistance in Serratia marcescens.
    Woods DR; Mosmann TR; Hanson S; Hendry DA
    J Bacteriol; 1971 Nov; 108(2):765-9. PubMed ID: 4942763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SELECTIVE INHIBITION OF PROLINE-INDUCED PIGMENTATION IN WASHED CELLS OF SERRATIA MARCESCENS.
    BLIZZARD JL; PETERSON GE
    J Bacteriol; 1963 May; 85(5):1136-40. PubMed ID: 14044006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and co-cultivation of two mutant strains harboring key precursor genes to produce prodigiosin.
    Chen WC; Tsai MJ; Soo PC; Wang LF; Tsai SL; Chang YK; Wei YH
    J Biosci Bioeng; 2018 Dec; 126(6):783-789. PubMed ID: 30401454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid profiles in pigmented and non-pigmented strains of S. marcescens.
    Pizzimenti FC; Nostro A; Marino A; Villari A; Verzera A; Trozzi A; Alonzo V
    New Microbiol; 1999 Apr; 22(2):91-8. PubMed ID: 10322607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A relationship between R plasmids and increased incidence of nonpigmenting drug-resistant Serratia marcescens from clinical sources].
    Muto Y; Tsuji A; Kaneko Y; Goto S
    Nihon Saikingaku Zasshi; 1982 Nov; 37(6):931-7. PubMed ID: 6763638
    [No Abstract]   [Full Text] [Related]  

  • 12. Thiamine-induced formation of the monopyrrole moiety of prodigiosin.
    Goldschmidt MC; Williams RP
    J Bacteriol; 1968 Sep; 96(3):609-16. PubMed ID: 4895047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and expression in Escherichia coli of Serratia marcescens genes encoding prodigiosin biosynthesis.
    Dauenhauer SA; Hull RA; Williams RP
    J Bacteriol; 1984 Jun; 158(3):1128-32. PubMed ID: 6233267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of pigmented and nonpigmented mutants of Serratia marcescens with reduced cell surface hydrophobicity.
    Rosenberg M
    J Bacteriol; 1984 Oct; 160(1):480-2. PubMed ID: 6384200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The red pigment prodigiosin is not an essential virulence factor in entomopathogenic Serratia marcescens.
    Zhou W; Li J; Chen J; Liu X; Xiang T; Zhang L; Wan Y
    J Invertebr Pathol; 2016 May; 136():92-4. PubMed ID: 27000435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intergeneric bacterial conjugation in crosses of Vibrio cholerae biotype proteus X Serratia marcescens].
    Sokurova EN; Polushkina EF; Golovina VS
    Genetika; 1982 Oct; 18(10):1603-12. PubMed ID: 6757054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of drug-resistance plasmids by conjugation from nosocomial strains of Serratia marcescens to Escherichia coli in biological fluids of human origin.
    Mendez FJ; Mendoza MC; Llaneza JJ; Hardisson C
    J Hosp Infect; 1982 Sep; 3(3):285-92. PubMed ID: 6183321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmid-determined resistance to fosfomycin in Serratia marcescens.
    Mendoza C; Garcia JM; Llaneza J; Mendez FJ; Hardisson C; Ortiz JM
    Antimicrob Agents Chemother; 1980 Aug; 18(2):215-9. PubMed ID: 7004337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defects in prodigiosin formation by L-forms of Serratia marcescens.
    Potter CS; Hubert EG; Montgomerie JZ; Kalmanson GM; Guze LB
    J Bacteriol; 1973 Dec; 116(3):1343-5. PubMed ID: 4584812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of class 1 integrons and antimicrobial resistance in CTX-M-3-producing Serratia marcescens isolates from southern Taiwan.
    Peng CF; Lee MF; Fu HT; Chen YJ; Hsu HJ
    Jpn J Infect Dis; 2007 Sep; 60(5):250-6. PubMed ID: 17881862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.